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INTRODUCTION:  The  only  means  of  achieving  long-term  survival  in hepatocellular  carcinoma  is  complete
tumor resection  or liver  transplantation.  Patients  with  large  hepatocellular  carcinomas  are  currently
not  considered  for liver  transplantation.  Associating  liver  partition  and portal  vein ligation  for  staged
hepatectomy  (ALPPS)  is  indicated  in selected  patients.  We  present  the  case  of  a  patient  with  a huge
hepatocellular  carcinoma  who  underwent  an  ALPPS  procedure.  PRESENTATION  OF  CASE:  A 57-year-old
man  initially  presented  with  a tumor  measuring  19 cm  × 10 cm in  the  right  lobe  of  the  liver. The liver
function  was  normal  and  there  was  no evidence  of portal  hypertension.  The  ﬁrst  part  of the  procedure
was  performed  without  mobilizing  the  liver.  The  middle  hepatic  vein  was  divided  during  parenchymal
transection.  The  second  procedure  was  performed  after  15 days.  During  that  procedure  the right  hepatic
artery,  right  bile  duct,  and  the  right  hepatic  vein  were  ligated  and  divided.  Liver  segments  4–8 with  the
tumor  were  removed.  The patient  developed  moderate  ascites  but  recovered  after  ten  days.  After  90  days,
the patient  is  doing  well  with  no  signs  of  recurrence.
DISCUSSION:  Hepatocellular  carcinoma  is  a complicated  disease  and  ALPPS  is  not  considered  an  optimal
treatment  option.  However,  patients  with  large  tumors  are  not  considered  for  liver transplantation  or
chemotherapy.  Patients  with  Child-Pugh  A  liver  disease  without  portal  hypertension  can  beneﬁt  from
surgical  treatment  for hepatocellular  carcinoma;  in some  situations,  surgery  may  be  considerably  better
than  other  forms  of  treatment.
CONCLUSION:  ALPPS  should  be  considered  in selected  patients  with  large  hepatocellular  carcinomas.
© 2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Hepatocellular carcinoma (HCC) is one of the most common
ancers worldwide, and occurs mainly in chronic liver disease or
irrhosis [1].
The only means of achieving chances to obtain long-term
urvival is complete tumor resection or liver transplantation.
ccording to tumor size, HCC larger than 10 cm is deﬁned as very
arge. The prognosis is poor and is associated with satellite nod-
les, macroscopic vascular invasion, and extra hepatic metastasis.
urgical resection is indicated in case of a single tumor of any size,
hild-Pugh class A, without portal hypertension or extra hepatic
isease [1,2].Associating liver partition and portal vein ligation for staged
epatectomy (ALPPS) is an important procedure to induce rapid
iver hypertrophy. The main indications for ALPPS are extensive
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bilobar colorectal liver metastases with a future liver remnant <25%
[3,4]. According to the ﬁrst international consensus meeting on
ALPPS, the procedure is indicated in selected patients with HCC
[5]. We  present the case of a patient with HCC larger than 10 cen-
timeters who  underwent an ALPPS procedure.
2. Presentation of case
A 57-year-old man  presented with epigastric discomfort and
weight loss. He had a history of heavy alcohol consumption, but
no history of hepatitis virus infection. Contrast-enhanced com-
puted tomography (CT) was  performed which revealed a large
tumor measuring 19 cm × 10 cm in segments 4–8, right portal vein
thrombosis, and no signs of liver cirrhosis (Fig. 1). Liver function
evaluation revealed albumin 3.8 g/dL, creatinine 1.2 mg/dL, inter-
national normalized ratio (INR) 1.0, and serum bilirubin 1.1 mg/dL;
he had, no ascites, no encephalopathy, a Child-Pugh score of A5,
Model for End-stage Liver Disease (MELD) score of 9, and a platelet
count of 123 × 103/mm3. The alpha-fetoprotein (AFP) level was
508 ng/mL. The case was  discussed in a multidisciplinary meeting
and ALPPS was indicated.
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. CT with huge HCC.
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After preoperative evaluation the patient underwent surgery. A
odiﬁed Makuuchi incision was used. A thorough exploration of
he abdomen was performed to assess and stage the liver tumors.
uring the ﬁrst procedure, the liver was not mobilized in order to
void adhesions in the second operation. The right portal vein was
issected and doubly ligated with a 2.0 silk tie and was  not divided.
edicles to segment 4 were ligated and divided. The transection
f the liver parenchyma was performed at 1 cm on the right side
f the falciform ligament using bipolar coagulation irrigated with
aline solution. The anterior approach was performed in order to
void tumor manipulation. An intermittent Pringle maneuver was
erformed during the parenchymal transection. The middle hepaticre with plastic bag.
vein was  divided during the transection, preserving the left hepatic
vein. The cut surface of the right liver was protected with a sterile
plastic bag for laparoscopy (Esterili-Med®) ﬁxed with 3.0 prolene,
and a hemostatic sponge (Surgicel®, Ethicon) was used on the left
side (Fig. 2). A silicone drain was placed on the transection line
of the liver and the abdomen was closed. The operating time was
175 min, the blood loss was  600 mL,  and no blood transfusion was
necessary after this procedure.
After 15 days, abdominal CT was performed and showed signif-
icant hypertrophy of the left lobe (Fig. 3).
The second operation started with the same incision and mobi-
lization of the right liver from the vena cava. The plastic bag was
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Fig. 3. CT 15 days after the ﬁrst procedure.
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emoved from the right extended lobe. The right hepatic artery, the
ight bile duct, and the right hepatic vein were ligated and divided.
iver segments 4–8 with the tumor were removed (Figs. 4 and 5).
wo silicone drains were placed and the abdomen closed. The
atient was sent to the intensive care unit, and an oral diet was
tarted on the second postoperative day. The operating time was
46 min, the blood loss was 1200 mL  and two units of blood were
ransfused after this procedure. After the second procedure, the
atient developed moderate ascites that was clinically treated. No
ile leak was observed and his liver function recovered well after
en days.Histopathology conﬁrmed a 19.4 cm × 10.5 cm HCC, steatosis,
umor necrosis, and presence of microscopic vascular invasion. The
esection margins were clear and the normal liver parenchyma
howed chronic hepatitis. The postoperative course was unevent-e liver remnant.
ful and the patient was discharged 28 days after the ﬁrst procedure.
After 90 days of follow-up, the patient is well, with no signs of
recurrence.
3. Discussion
HCC is a complicated and heterogeneous disease. Liver resection
is indicated in early-stage patients without cirrhosis or who have
well-preserved liver function and an anticipated liver remnant of
at least 25%. This is possible in fewer than 5% of patients. Liver
transplantation is indicated in patients with a single nodule up to
5 cm in size or up to three nodules up to 3 cm in size each [1,2]. In
this case, the patient was  not a candidate for liver transplantation,
as he had a 19 cm tumor.
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The ALPPS procedure has been employed to improve resection,
hen a small liver remnant is expected. It is a controversial proce-
ure in liver surgery and is still being debated in surgical meetings
round the world. A hepato-pancreatobiliary surgeon who  per-
orms ALPPS has to know that not all patients with HCC are suitable
or this procedure and has to weigh the beneﬁt of achieving com-
lete resection against the risk of complications of this extensive
rocedure [6–8]. Remarkable hypertrophy is observed in ALPPS,
ven in patients with low-grade ﬁbrosis, even greater than that
fter portal vein embolization [7,8,10].
A high rate of mortality and complications seem to be associated
ore with HCC than with colorectal liver metastases [4,6]. In the
resent case the patient was classiﬁes as Child-Pugh class A, with
o portal hypertension and excellent status performance. The pro-
edure was very useful as the patient had portal vein thrombosis
nd no opportunity to perform portal vein embolization.
The strict selection of patients enables some groups to per-
orm ALPPS with low mortality [6]. According to Schadde et al.,
mong 15 patients with HCC who underwent ALPPS, incomplete
esection was not observed, disease-free survival at one year was
7%, Clavien-Dindo complications ≥IIIb were 25% (colorectal liver
etastasis 21%, p > 0.05), and 90-day mortality was 12% [5]. During
he transection, the anterior approach can result in minor intraop-
rative blood loss and the need for perioperative blood transfusions.
his procedure results in reduced morbidity and mortality [8–10].
n the present case, we performed an anterior approach to minimize
omplications.
Bjornsson et al. reported no 90-day mortality or severe compli-
ations (grade ≥ 3B) in patients who underwent ALPPS for primary
epatobiliary malignancies. The postoperative hospital stay after
he stage 2 operation was 13.5 days [9].
ALPPS is an aggressive surgical approach for tumors unre-
ectable in a single stage, and an accepted alternative for a huge
CC. However, it should be reserved for patients who  are not can-
idates for portal vein embolization due to previous invasion of
he portal vein branch, or with failed portal vein embolization
r ligation. The choice of treatment with ALPPS is inﬂuenced by
actors such as availability of resources and expertise. The progno-n of HCC.
sis of a huge HCC treated with aggressive surgery is signiﬁcantly
better than that treated with transarterial chemoembolization or
sorafenib [9,10].
4. Conclusion
ALPPS seems to be feasible and should be performed in patients
with a huge HCC. This strategy represents a chance of cure for
patients who are candidates for palliative treatment. A careful
selection of patients with the lowest perioperative risk is neces-
sary. However, this procedure should be performed in centers with
expertise in hepato-biliary surgery.
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